Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/1996
08/22/1996WO1996025184A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression
08/22/1996WO1996025158A1 Medicinal composition containing azulene derivative and process for producing the same
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0727211A1 Use of src SH2 specific compounds to treat a bone resorption disease
08/21/1996EP0726913A1 Cytokines from natural killer or t cells
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726705A1 APPARATUS FOR EARLY EMBRYONIC $i(IN OVO) INJECTION
08/21/1996EP0726704A1 Method of introducing material into eggs during early embryonic development
08/21/1996EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells
08/21/1996CN1129104A Total parenteral nutrition solution containing water-soluble vitamin B
08/20/1996US5547988 Topical application to reduce appearance of skin aging
08/20/1996US5547969 Method for the treatment of bradyphrenia in Parkinson's disease patients
08/20/1996US5547968 Treatment of ocular hypertension with a synergistic combination
08/20/1996US5547956 Pharmaceutical composition and the method for treating drug addicts' withdrawal syndromes and detoxifying addicts by the same
08/20/1996US5547946 Topical pharmaceutical compositions for respiratory allergies
08/20/1996US5547677 Antimicrobial oil-in-water emulsions
08/20/1996US5547662 Preparation of a skin surface for a surgical procedure
08/20/1996CA2017155C Method for transplantation of fertilized ova
08/15/1996WO1996024684A1 Potentiators of antibacterial agents
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024375A1 New oral pharmaceutical dosage form
08/15/1996WO1996024373A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996WO1996024372A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996WO1996024367A1 Pharmaceutical composition for the treatment of herpes
08/15/1996WO1996024357A1 Novel glucocorticoid response elements
08/15/1996WO1996024355A1 Novel pharmaceutical combination
08/15/1996WO1996024353A1 Methods of treating or preventing psychiatric disorders
08/15/1996WO1996024348A2 Use of carbazole compounds for the treatment of congestive heart failure
08/15/1996WO1996024343A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996WO1996024342A1 Concomitant treatment with oral bismuth compounds
08/15/1996WO1996024341A1 Concomitant treatment with bismuth and antibacterials
08/15/1996WO1996024338A1 New pharmaceutical formulation and process
08/15/1996WO1996018738A3 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
08/15/1996CA2212713A1 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996CA2212712A1 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212645A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996CA2212464A1 Potentiators of antibacterial agents
08/15/1996CA2212379A1 Novel glucocorticoid response elements
08/14/1996EP0726072A2 Composition for the treatment of hypertension and congestive heart failure, containing an angiotensin II antagonist and an endopeptidase inhibitor
08/14/1996EP0725826A1 Improvements relating to cancer therapy
08/14/1996EP0725789A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
08/14/1996EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
08/14/1996EP0725645A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
08/14/1996EP0725638A1 Treatment of laminitis
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725630A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
08/14/1996EP0471751B1 Antineoplastic solution and method for treating neoplasms
08/14/1996CN1128950A Method for modulating human sexual response
08/14/1996CN1128946A Transfusion container, transfusion prepn., and comprehensive vitamin-containing high-calorie transfusion prepn.
08/13/1996US5545631 N-substituted aminoalkanephosphinic acid derivatives, compositions thereof, and their use as anti-epileptics
08/13/1996US5545625 Hypotensive therapy
08/13/1996US5545617 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
08/13/1996US5545614 Controlling nitrogen oxide concentrations to modulate skeletal muscle contraction
08/13/1996US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996CA1338519C Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
08/11/1996CA2169136A1 Use of src sh2 specific compounds to treat a bone resorption disease
08/11/1996CA2169132A1 Use of hcp sh2 specific compounds to enhance erythropoiesis
08/09/1996CA2168066A1 Treatment of hypertension and congestive heart failure
08/08/1996WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023506A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
08/08/1996WO1996023503A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
08/08/1996WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
08/08/1996WO1996023495A1 Novel medical use of heme products
08/08/1996WO1996023494A1 Oral compositions of h2-antagonists
08/08/1996WO1996023490A1 Formulations and methods for reducing skin irritation
08/08/1996DE19503934A1 Prodn. of oral active agent against ozone damage
08/08/1996CA2212127A1 Formulations and methods for reducing skin irritation
08/08/1996CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
08/08/1996CA2211445A1 Novel medical use of heme products
08/07/1996EP0724842A2 Preparation for the treatment of obesity
08/07/1996EP0724449A1 Preservative for pharmaceutical products
08/07/1996EP0724443A1 Methods and compositions for lowering intraocular pressure
08/07/1996EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
08/07/1996EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists
08/07/1996EP0661981B1 Use of hyaluronic acid and forms to prevent arterial restenosis
08/07/1996CN1128496A Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
08/06/1996US5543430 Method and formulation of stimulating nitric oxide synthesis
08/06/1996US5543417 Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023059A1 Lineage-directed induction of human mesenchymal stem cell differentiation
08/01/1996WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness
08/01/1996WO1996022791A1 Novel synergistic compositions useful as anti-tumor or anti-retroviral agents
08/01/1996WO1996022790A1 Composition to ameliorate osteolysis and metastasis
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996WO1996022777A1 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
08/01/1996DE19502789A1 Medicament contg. analgesic, antacid, and/or vitamin etc.
07/1996
07/31/1996EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde
07/31/1996EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP
07/31/1996EP0723460A1 Gene therapy of the nervous system
07/31/1996EP0723458A1 Immune modulation with class ii alpha-chain fragments
07/31/1996EP0723457A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
07/31/1996EP0723455A1 Methods of inhibiting phagocytosis
07/31/1996EP0723443A1 Use of alpha receptor antagonists for the treatment of chronic muscle pain
1 ... 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 ... 1151